share_log

Renalytix Analyst Ratings

Renalytix Analyst Ratings

Renalytix分析師評級
Benzinga Analyst Ratings ·  2022/12/03 02:32
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
12/02/2022 300% HC Wainwright & Co. $10 → $8 Maintains Buy
11/01/2022 400% HC Wainwright & Co. $15 → $10 Maintains Buy
07/01/2022 150% BTIG $15 → $5 Maintains Buy
07/01/2022 250% Stifel $17 → $7 Maintains Buy
07/01/2022 650% HC Wainwright & Co. $30 → $15 Maintains Buy
01/18/2022 1400% HC Wainwright & Co. → $30 Initiates Coverage On → Buy
01/04/2022 1100% BTIG → $24 Initiates Coverage On → Buy
07/02/2021 1800% Berenberg → $38 Initiates Coverage On → Buy
08/11/2020 1000% Stifel → $22 Initiates Coverage On → Buy
日期 上行/下行 分析公司 目標價格變化 評級變化 上一次/當前評級
12/02/2022 300% HC Wainwright公司 $10 → $8 維護
11/01/2022 400% HC Wainwright公司 $15 → $10 維護
07/01/2022 150% BTIG $15 → $5 維護
07/01/2022 250% Stifel $17 → $7 維護
07/01/2022 650% HC Wainwright公司 $30 → $15 維護
01/18/2022 1400% HC Wainwright公司 → $30 開始承保 →購買
01/04/2022 1100% BTIG → $24 開始承保 →購買
07/02/2021 1800% 貝倫伯格 → $38 開始承保 →購買
08/11/2020 1000% Stifel → $22 開始承保 →購買

What is the target price for Renalytix (RNLX)?

Renalytix的目標價是多少?

The latest price target for Renalytix (NASDAQ: RNLX) was reported by HC Wainwright & Co. on December 2, 2022. The analyst firm set a price target for $8.00 expecting RNLX to rise to within 12 months (a possible 300.00% upside). 7 analyst firms have reported ratings in the last year.

HC Wainwright&Co.於2022年12月2日報道了Renalytix(納斯達克代碼:RNLX)的最新目標價。這家分析公司將目標價定為8美元,預計RNLX將在12個月內上漲至(可能上漲300.00%)。去年有7家分析公司公佈了評級。

What is the most recent analyst rating for Renalytix (RNLX)?

分析師對Renalytix的最新評級是多少?

The latest analyst rating for Renalytix (NASDAQ: RNLX) was provided by HC Wainwright & Co., and Renalytix maintained their buy rating.

分析師對Renalytix(納斯達克代碼:RNLX)的最新評級由HC Wainwright&Co.提供,Renalytix維持買入評級。

When is the next analyst rating going to be posted or updated for Renalytix (RNLX)?

Renalytix(RNLX)的下一次分析師評級將於何時發佈或更新?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Renalytix, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Renalytix was filed on December 2, 2022 so you should expect the next rating to be made available sometime around December 2, 2023.

分析師在進行了廣泛的研究後得出了股票評級,其中包括查閲公開財務報表,與Renalytix的高管和客户交談,以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次,所以你每年應該會得到每家公司每家公司的4個評級。Renalytix的上一次評級是在2022年12月2日提交的,因此您應該預計下一次評級將在2023年12月2日左右提供。

Is the Analyst Rating Renalytix (RNLX) correct?

分析師對Renalytix的評級正確嗎?

While ratings are subjective and will change, the latest Renalytix (RNLX) rating was a maintained with a price target of $10.00 to $8.00. The current price Renalytix (RNLX) is trading at is $2.00, which is out of the analyst's predicted range.

雖然評級是主觀的,並將發生變化,但最新的Renalytix(RNLX)評級維持不變,目標價在10.00美元至8.00美元之間。Renalytix(RNLX)目前的交易價格為2.00美元,超出了分析師的預測區間。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論